CTLA4 and colorectal carcinoma: A cancer antigen called MAGE-A is associated with resistance to CTLA-4 inhibitors and inhibits autophagy, suggesting that autophagy induction could be used therapeutically to improve the efficacy of CTLA-4 inhibitors in tumors [46], further experiments are needed to explore the crosstalk of autophagy and immune checkpoints in CRC.